In microarray gene expression experiments, several diverse conditions in each experiment (e.g., time, doses, replicates) increase the data points from tens of thousands of measurements for a single ...

Microarray expression profiling is instrumental to our understanding of the function of the genome. Resolution of functionally relevant expression patterns will require the analysis of large data sets ...

Microarrays first appeared on the scene around 1995, and it was not long before their use became quite widespread. Early analyses were modelled on those of the pioneers. By around 2000, however, ...

Expression Analysis says it has completed a significant milestone in a “mock-submission of microarray data” being prepared for the FDA. The company also has named Thomas Goralski as laboratory ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Spotfire, Inc. has announced DecisionSite® for Microarray Analysis (DSMA), which gives drug makers a competitive advantage in quickly and accurately identifying potential drug targets. DSMA, available ...

The power and promise of microarrays are vast. Offering the ability to run tens of thousands of experiments in parallel on a small glass slide, gene chips have transformed functional genomics, whether ...

Consider the ranking of genes using data from replicated microarray time course experiments, where there are multiple biological conditions, and the genes of interest are those whose temporal profiles ...

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer Identifying sources of variation in expression microarray data and the effect of variance in gene ...

Ron Peterson, lab head at Novartis Institutes of Biomedical Research, is preparing for a wave of new studies using microarrays. A workhorse genetic testing tool called a microarray got a lot more ...